(CRAI) CRA International - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12618T1051

Consulting Services, Economic Analysis, Expert Testimony, Market Research

Stock: Research & Consulting Services
Age 27.8y

MCap 1,388m
Avg Vol 127K (26.9M USD)

Beta 0.659
Volatility 32.63%

EPS (Earnings per Share)

EPS CAGR: 17.09%
EPS Trend: 64.3%

Last SUE: 1.03
Qual. Beats: 1

Revenue

Rev. CAGR: 8.96%
Rev. Trend: 94.5%

Last SUE: 0.92
Qual. Beats: 2

Dividends

Dividend Yield	1.35%
Yield on Cost 5y	4.54%
Yield CAGR 5y	23.43%
Payout Consistency	100.0%
Payout Ratio	24.9%

Risk via 5d forecast
Volatility	32.6%
Value at Risk 5%th	49.7%
Relative Tail Risk	-7.39%

Reward TTM
Sharpe Ratio	0.41
Alpha	3.85
CAGR/Max DD	0.71

Character TTM
Hurst Exponent	0.644
Beta	0.659
Beta Downside	0.702

Drawdowns 3y
Max DD	33.06%
Mean DD	11.32%
Median DD	11.35%

Description: CRAI CRA International January 20, 2026

CRA International Inc. (NASDAQ:CRAI) is a Boston-based global consulting firm that delivers economic, financial and management advisory services. Its core offerings include expert testimony and analytical support for litigation and regulatory matters across finance, accounting, economics, insurance and forensic investigations, as well as strategic consulting such as performance improvement, ESG and sustainability strategy, market demand estimation, and intellectual-property valuation.

In FY 2023 the company generated roughly $460 million in revenue, with an operating margin near 14%, reflecting steady demand for high-margin forensic and ESG consulting. A key economic driver is the rising volume of corporate litigation and regulatory scrutiny, which has boosted the forensics segment by an estimated 8% YoY. Additionally, the ESG consulting line is expanding at a compound annual growth rate of about 12% as investors and regulators tighten sustainability reporting standards.

If you want a data-rich, model-driven perspective on CRAI’s valuation and risk profile, the ValueRay platform provides a useful starting point for deeper analysis.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income: 56.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.39 > 1.0
NWC/Revenue: -4.52% < 20% (prev 2.57%; Δ -7.09% < -1%)
CFO/TA 0.07 > 3% & CFO 41.8m > Net Income 56.6m
Net Debt (171.8m) to EBITDA (113.6m): 1.51 < 3
Current Ratio: 0.90 > 1.5 & < 3
Outstanding Shares: last quarter (6.62m) vs 12m ago -3.24% < -2%
Gross Margin: 31.00% > 18% (prev 0.29%; Δ 3072 % > 0.5%)
Asset Turnover: 120.7% > 50% (prev 115.5%; Δ 5.20% > 0%)
Interest Coverage Ratio: 16.96 > 6 (EBITDA TTM 113.6m / Interest Expense TTM 4.99m)

Altman Z'' 2.19

A: -0.05 (Total Current Assets 305.6m - Total Current Liabilities 338.6m) / Total Assets 629.0m
B: 0.34 (Retained Earnings 211.7m / Total Assets 629.0m)
C: 0.14 (EBIT TTM 84.6m / Avg Total Assets 605.7m)
D: 0.47 (Book Value of Equity 201.7m / Total Liabilities 427.4m)
Altman-Z'' Score: 2.19 = BBB

Beneish M -2.95

DSRI: 1.00 (Receivables 264.0m/243.3m, Revenue 731.1m/672.6m)
GMI: 0.92 (GM 31.00% / 28.56%)
AQI: 1.10 (AQ_t 0.32 / AQ_t-1 0.29)
SGI: 1.09 (Revenue 731.1m / 672.6m)
TATA: 0.02 (NI 56.6m - CFO 41.8m) / TA 629.0m)
Beneish M-Score: -2.95 = A

ValueRay F-Score (Strict, 0-100) 81.93

1. Piotroski: 7.0pt
2. FCF Yield: 1.82%
3. FCF Margin: 3.89%
4. Debt/Equity: 0.96
5. Debt/Ebitda: 1.51
6. ROIC - WACC: 13.62%
7. RoE: 27.01%
8. Revenue Trend: 94.55%
9. EPS Trend: 64.31%

What is the price of CRAI shares?

As of January 24, 2026, the stock is trading at USD 209.05 with a total of 75,832 shares traded.
Over the past week, the price has changed by -0.80%, over one month by -0.15%, over three months by +11.49% and over the past year by +12.78%.

Is CRAI a buy, sell or hold?

CRA International has received a consensus analysts rating of 3.50. Therefor, it is recommend to hold CRAI.

Strong Buy: 0
Buy: 1
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the CRAI price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	252.5	20.8%
Analysts Target Price	252.5	20.8%
ValueRay Target Price	250.6	19.9%

CRAI Fundamental Data Overview January 19, 2026

P/E Trailing = 25.3293
P/E Forward = 23.6967
P/S = 1.898
P/B = 6.8579
P/EG = 1.48
Revenue TTM = 731.1m USD
EBIT TTM = 84.6m USD
EBITDA TTM = 113.6m USD
Long Term Debt = 99.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 113.7m USD (from shortTermDebt, last quarter)
Debt = 194.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 171.8m USD (from netDebt column, last quarter)
Enterprise Value = 1.56b USD (1.39b + Debt 194.3m - CCE 22.5m)
Interest Coverage Ratio = 16.96 (Ebit TTM 84.6m / Interest Expense TTM 4.99m)
EV/FCF = 54.86x (Enterprise Value 1.56b / FCF TTM 28.4m)
FCF Yield = 1.82% (FCF TTM 28.4m / Enterprise Value 1.56b)
FCF Margin = 3.89% (FCF TTM 28.4m / Revenue TTM 731.1m)
Net Margin = 7.74% (Net Income TTM 56.6m / Revenue TTM 731.1m)
Gross Margin = 31.00% ((Revenue TTM 731.1m - Cost of Revenue TTM 504.4m) / Revenue TTM)
Gross Margin QoQ = 27.40% (prev 31.22%)
Tobins Q-Ratio = 2.48 (Enterprise Value 1.56b / Total Assets 629.0m)
Interest Expense / Debt = 0.90% (Interest Expense 1.75m / Debt 194.3m)
Taxrate = 29.28% (4.75m / 16.2m)
NOPAT = 59.8m (EBIT 84.6m * (1 - 29.28%))
Current Ratio = 0.90 (Total Current Assets 305.6m / Total Current Liabilities 338.6m)
Debt / Equity = 0.96 (Debt 194.3m / totalStockholderEquity, last quarter 201.7m)
Debt / EBITDA = 1.51 (Net Debt 171.8m / EBITDA 113.6m)
Debt / FCF = 6.05 (Net Debt 171.8m / FCF TTM 28.4m)
Total Stockholder Equity = 209.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 9.34% (Net Income 56.6m / Total Assets 629.0m)
RoE = 27.01% (Net Income TTM 56.6m / Total Stockholder Equity 209.5m)
RoCE = 27.38% (EBIT 84.6m / Capital Employed (Equity 209.5m + L.T.Debt 99.3m))
RoIC = 21.02% (NOPAT 59.8m / Invested Capital 284.5m)
WACC = 7.39% (E(1.39b)/V(1.58b) * Re(8.34%) + D(194.3m)/V(1.58b) * Rd(0.90%) * (1-Tc(0.29)))
Discount Rate = 8.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF Debug] Terminal Value 78.89% ; FCFF base≈26.7m ; Y1≈24.1m ; Y5≈20.7m
Fair Price DCF = 37.97 (EV 421.0m - Net Debt 171.8m = Equity 249.2m / Shares 6.56m; r=7.39% [WACC]; 5y FCF grow -12.14% → 2.90% )
EPS Correlation: 64.31 | EPS CAGR: 17.09% | SUE: 1.03 | # QB: 1
Revenue Correlation: 94.55 | Revenue CAGR: 8.96% | SUE: 0.92 | # QB: 2
EPS next Quarter (2026-03-31): EPS=2.25 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=8.91 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+8.1% | Growth Revenue=+3.7%

Additional Sources for CRAI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle